CRISPR

NGS workflow solutions enable scientists to focus on more valuable tasks such as interpreting data and making discoveries

The test aims to help CLIA labs boost testing capacity

The mCARMEN platform is being used during the Omicron surge to help guide public health efforts in Massachusetts

Research from this past year highlights the potential of CRISPR-Cas9 technology in modeling and treating rare disease

From leadership and management to COVID-19 and cancer, explore Clinical Lab Manager's most read stories of 2021

Transposons have the potential to make DNA editing easier, cheaper, and safer

SENSR adds to the toolkit of quick-turnaround diagnostics needed for future pandemics

Low-cost device could allow consumers to test themselves for multiple strains of SARS-CoV-2 at home

The inexpensive assay can detect HPV DNA in human samples but could be modified to diagnose other viral infections

The CRISPR-based method is highly multiplexable and could detect several disease-related biomarkers in one test